Sakanashi M, Noguchi K, Matsuzaki T, Ojiri Y, Nakasone J, Itomine T, Higuchi M, Shiroma N
Department of Pharmacology, School of Medicine, Faculty of Medicine, University of the Ryukyus, Okinawa, Japan.
Cardioscience. 1993 Dec;4(4):241-50.
The effects of pilsicainide, propafenone and flecainide on systemic hemodynamics and cardiac function were compared in anesthetized open-chest dogs. Pilsicainide, propafenone and flecainide given intravenously at 1 and 3 mg/kg produced dose-dependent decreases in the mean aortic pressure. The heart rate was decreased by pilsicainide and flecainide, but not by propafenone. The three drugs increased the left ventricular end-diastolic pressure and reduced the first derivative of left ventricular pressure and myocardial oxygen consumption. Pilsicainide decreased aortic, vertebral, coronary and renal blood flows in a dose-dependent manner at 1 and 3 mg/kg. Propafenone increased aortic and vertebral blood flows at 1 mg/kg and decreased coronary and renal blood flows at 3 mg/kg. Flecainide did not significantly change blood flow, except for an increase in the aortic blood flow with 3 mg/kg. The total peripheral, vertebral, coronary and renal vascular resistances were increased by pilsicainide, but not by flecainide. Propafenone decreased total peripheral and vertebral vascular resistances, but hardly affected the coronary and renal vascular resistances. The stroke volume was decreased by 1 and 3 mg/kg pilsicainide in a dose-dependent manner, and increased by 1 and 3 mg/kg propafenone, but not significantly changed by 1 or 3 mg/kg flecainide. The stroke work index was decreased by 3 mg/kg pilsicainide and 3 mg/kg flecainide. The effects of pilsicainide correlated with the changes in its plasma concentration with time. The results indicate that pilsicainide has a negative inotropic activity similar to that of propafenone and flecainide. Pilsicainide and flecainide show almost the same effects with a slightly different efficacy, while propafenone exerts different effects upon some cardiovascular functions.
在麻醉开胸犬中比较了吡西卡尼、普罗帕酮和氟卡尼对全身血流动力学和心脏功能的影响。静脉注射1mg/kg和3mg/kg的吡西卡尼、普罗帕酮和氟卡尼可使平均主动脉压呈剂量依赖性降低。吡西卡尼和氟卡尼可使心率降低,但普罗帕酮无此作用。这三种药物均可增加左心室舒张末期压力,降低左心室压力的一阶导数和心肌耗氧量。1mg/kg和3mg/kg的吡西卡尼可使主动脉、椎动脉、冠状动脉和肾血流量呈剂量依赖性减少。1mg/kg的普罗帕酮可增加主动脉和椎动脉血流量,3mg/kg时可减少冠状动脉和肾血流量。除3mg/kg时主动脉血流量增加外,氟卡尼对血流无明显影响。吡西卡尼可增加总外周、椎动脉、冠状动脉和肾血管阻力,而氟卡尼则无此作用。普罗帕酮可降低总外周和椎动脉血管阻力,但对冠状动脉和肾血管阻力影响不大。1mg/kg和3mg/kg的吡西卡尼可使每搏量呈剂量依赖性减少,1mg/kg和3mg/kg的普罗帕酮可使每搏量增加,而1mg/kg或3mg/kg的氟卡尼对每搏量无明显影响。3mg/kg的吡西卡尼和3mg/kg的氟卡尼可使每搏功指数降低。吡西卡尼的作用与其血浆浓度随时间的变化相关。结果表明,吡西卡尼具有与普罗帕酮和氟卡尼相似的负性肌力活性。吡西卡尼和氟卡尼的作用几乎相同,只是效力略有差异,而普罗帕酮对某些心血管功能有不同的影响。